{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T18:43:04Z","timestamp":1747075384033},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T00:00:00Z","timestamp":1452729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0146772","type":"journal-article","created":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T02:20:45Z","timestamp":1452824445000},"page":"e0146772","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Carpal Tunnel Syndrome Associated with Oral Bisphosphonates. A Population-Based Cohort Study"],"prefix":"10.1371","volume":"11","author":[{"given":"Alfonso","family":"Carvajal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis H.","family":"Mart\u00edn Arias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"S\u00e1inz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Escudero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Fierro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odile","family":"Sauzet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria R.","family":"Cornelius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Molokhia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,1,14]]},"reference":[{"issue":"1","key":"ref1","first-page":"CD001155","article-title":"Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women","author":"GA Wells","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00228-007-0320-6","article-title":"Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005","volume":"63","author":"J Watson","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/BOR.0b013e32832ca433","article-title":"Osteoporosis treatments and adverse events","volume":"21","author":"DH Solomon","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00198-012-2158-8","article-title":"Bisphosphonate treatment and risk of esophageal cancer: a meta-analysis of observational studies","volume":"24","author":"K Sun","year":"2013","journal-title":"Osteoporos Int"},{"key":"ref5","first-page":"346","article-title":"Alendronate and risedronate: reports of severe bone, joint, and muscle pain","volume":"165","author":"DK Wysowski","year":"2005","journal-title":"Arch Int Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1210\/jc.2010-0597","article-title":"Characterization of and risk factors for the acute-phase response after zoledronic acid","volume":"95","author":"IR Reid","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","unstructured":"EMA [Internet]. London: European Medicines Agency.Alendronic acid (Adrovance). Summary of Product Characteristics. 2012 Jan [accesed 2015 Jan 3].Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000759\/WC500022038.pdf\" xlink:type=\"simple\">http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000759\/WC500022038.pdf<\/ext-link>"},{"key":"ref8","unstructured":"FDA [Internet]. Maryland: Food and Drug Administration. Alendronic acid (Fosamax). Full Prescribing Information. 2015 Nov [accessed 2015 Jan 3]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/020560s069,021575s025lbl.pdf\" xlink:type=\"simple\">http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/020560s069,021575s025lbl.pdf<\/ext-link>."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/bmj.330.7482.74","article-title":"Synovitis induced by alendronic acid can present as acute carpal tunnel syndrome","volume":"330","author":"DG Jones","year":"2005","journal-title":"BMJ"},{"key":"ref10","first-page":"1583","article-title":"Persistent polyarticular synovitis after treatment with alendronate","volume":"169","author":"L Frederiksen","year":"2007","journal-title":"Ugeskr Laeger"},{"key":"ref11","first-page":"537","article-title":"Alendronate-induced synovitis","volume":"35","author":"DP Gwynne Jones","year":"2008","journal-title":"J Rheumatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/bmj.39282.623553.AD","article-title":"Carpal tunnel syndrome","volume":"335","author":"JD Bland","year":"2007","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJMcp013018","article-title":"Clinical practice. Carpal tunnel syndrome","volume":"346","author":"JN Katz","year":"2002","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/rheumatology\/ker108","article-title":"Carpal tunnel syndrome and its relationship to occupation: a meta-analysis","volume":"51","author":"A Barcenilla","year":"2012","journal-title":"Rheumatology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/art.10395","article-title":"The genetic contribution to carpal tunnel syndrome in women: a twin study","volume":"47","author":"AJ Hakim","year":"2002","journal-title":"Arthritis Rheum"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhsb.2005.06.019","article-title":"A longitudinal study of predictors of research-defined carpal tunnel syndrome in industrial workers: findings at 17 years","volume":"30","author":"PA Nathan","year":"2005","journal-title":"J Hand Surg Br"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/oemed-2013-101365","article-title":"Personal and workplace psychosocial risk factors for carpal tunnel syndrome: a pooled study cohort","volume":"70","author":"C Harris-Adamson","year":"2013","journal-title":"Occup Environ Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1192\/bjp.153.2.250","article-title":"Lithium-induced carpal tunnel syndrome","volume":"153","author":"MP Deahl","year":"1988","journal-title":"Br J Psychiatry"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/oxfordjournals.aje.a010244","article-title":"Carpal tunnel syndrome: a nested case-control study of risk factors in women","volume":"151","author":"S Ferry","year":"2000","journal-title":"Am J Epidemiol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1470-2045(11)70328-X","article-title":"Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2\u20133 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study","volume":"13","author":"JS Mieog","year":"2012","journal-title":"Lancet Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e1286","DOI":"10.3928\/01477447-20120725-37","article-title":"Atraumatic acute carpal tunnel syndrome in a patient taking dabigatran","volume":"35","author":"PA Sibley","year":"2012","journal-title":"Orthopedics"},{"key":"ref22","unstructured":"Blak BT, Thompson M Bourke A (2006) National Representativeness and Data Quality of the Health Improvement Network (THIN) Database of Primary Care Information for Epidemiological Research. 9th annual conference of the UK Federation of Primary Care Research Organisations, Liverpool"},{"key":"ref23","first-page":"171","article-title":"Feasibility study and methodology to create a quality evaluated database of primary care data","volume":"12","author":"A Bourke","year":"2004","journal-title":"Inform Prim Care"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/bmj.300.6732.1092","article-title":"The Read clinical classification","volume":"300","author":"J Chisholm","year":"1990","journal-title":"BMJ"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/pds.1335","article-title":"Validation studies of The Health Improvement Network (THIN) database for pharmacoepidemiology research","volume":"16","author":"JD Lewis","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1468-1331.2011.03440.x","article-title":"Medical and non-medical correlates of carpal tunnel syndrome in a Taiwan cohort of one million","volume":"19","author":"CH Tseng","year":"2012","journal-title":"Eur J Neurol"},{"key":"ref27","unstructured":"FDA [Internet]. Maryland: Food and Drug Administration. Severe pain with osteoporosis drugs. 2008 Jul [accessed 2015 Jan 3]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm124165.htm\" xlink:type=\"simple\">http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm124165.htm<\/ext-link>"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/jbmr.5650100617","article-title":"Interleukin-6 and the acute phase response during treatment of patients with Paget&apos;s disease with the nitrogen-containing bisphosphonate dimethylaminohydroxypropylidene bisphosphonate","volume":"10","author":"DH Schweitzer","year":"1995","journal-title":"J Bone Miner Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/8756-3282(95)00448-3","article-title":"Interleukin-6 and tumor necrosis factor alpha levels after bisphosphonates treatment in vitro and in patients with malignancy","volume":"18","author":"A Sauty","year":"1996","journal-title":"Bone"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s002239900353","article-title":"An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates","volume":"61","author":"D Thiebaud","year":"1997","journal-title":"Calcif Tissue Int"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3346\/jkms.2010.25.9.1277","article-title":"Acute effects of intravenous administration of pamidronate in patients with osteoporosis","volume":"25","author":"MJ Lim","year":"2010","journal-title":"J Korean Med Sci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/jbmr.5650070507","article-title":"Retention of etidronate in human, dog, and rat","volume":"7","author":"GB Kasting","year":"1992","journal-title":"J Bone Miner Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00198-006-0322-8","article-title":"A systematic review of persistence and compliance with bisphosphonates for osteoporosis","volume":"18","author":"JA Cramer","year":"2007","journal-title":"Osteoporos Int"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0146772","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T02:43:30Z","timestamp":1540349010000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0146772"}},"subtitle":[],"editor":[{"given":"Chi-Ling","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,1,14]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0146772","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,14]]}}}